Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Short term Debt: 2015-2019

Historic Short term Debt for Fortress Biotech (FBIO) over the last 5 years, with Dec 2019 value amounting to $27,000.

  • Fortress Biotech's Short term Debt was N/A to $413,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $413,000, marking a year-over-year change of. This contributed to the annual value of $27,000 for FY2019, which is 97.28% down from last year.
  • Fortress Biotech's Short term Debt amounted to $27,000 in FY2019, which was down 97.28% from $991,000 recorded in FY2018.
  • In the past 5 years, Fortress Biotech's Short term Debt ranged from a high of $991,000 in FY2018 and a low of $27,000 during FY2019.
  • For the 3-year period, Fortress Biotech's Short term Debt averaged around $442,333, with its median value being $309,000 (2017).
  • As far as peak fluctuations go, Fortress Biotech's Short term Debt spiked by 321.93% in 2016, and later slumped by 97.28% in 2019.
  • Over the past 5 years, Fortress Biotech's Short term Debt (Yearly) stood at $114,000 in 2015, then spiked by 321.93% to $481,000 in 2016, then slumped by 35.76% to $309,000 in 2017, then surged by 220.71% to $991,000 in 2018, then tumbled by 97.28% to $27,000 in 2019.